Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04975464 · ClinicalTrials.gov registry record
BRINK (BRain In Kidney Disease) Memory Study 2.0
A clinical trial of Stroke and Diabetes, sponsored by Anne Murray.
- Active
- Registry status
- 600
- Enrollment target
- 2
- Study locations
NCT04975464: Active study of Stroke and Diabetes, sponsored by Anne Murray.
NCT04975464 is a study of Stroke and Diabetes that is active but no longer recruiting, run by Anne Murray. The registered enrollment target is 600 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04975464, a study of Stroke and Diabetes, is active but no longer recruiting, sponsored by Anne Murray.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this study, the investigators will be looking at results of tests of memory and thinking and daily activities in a group of people without known chronic kidney disease (CKD) , and a group of CKD patients, and follow the participants for up to four more years, including after the participants start dialysis or receive a transplant. The investigators are doing this study to compare how often memory loss, confusion and difficulty with daily activities occur in those without and those with CKD. Additionally, the investigators are doing this study to identify risk factors for memory and thinking problems in CKD patients. The information received through the NDI will be utilized to help track our study population and help provide useful information regarding cause of death of those in our study.
Primary Outcome
A screening interview will be conducted via telephone to determine eligibility (using criteria listed below) to continue to participate in BRINK 2.0 when scheduling the first visit.
Conditions Studied
Study Locations (2)
Minnesota
- Minneapolis VA Healthcare System - Minneapolis
- Hennepin Healthcare Research Institute - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2011-11-15 |
| Est. Completion | 2026-05 |
What the registry record for NCT04975464 still lists
NCT04975464 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower).
The record links to 10 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT04975464 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04975464 about?
NCT04975464 is a clinical study titled "BRINK (BRain In Kidney Disease) Memory Study 2.0". In this study, the investigators will be looking at results of tests of memory and thinking and daily activities in a group of people without known chronic kidney disease (CKD) , and a group of CKD patients, and follow the participants for up to four more years, including after the participants star...
What is the current status of trial NCT04975464?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2011-11-15. Estimated completion is 2026-05.
What conditions does trial NCT04975464 study?
This clinical trial studies the following conditions: Stroke, Diabetes, Alzheimer Disease, Dementia, Cognitive Impairment.
Who is sponsoring clinical trial NCT04975464?
This trial is sponsored by Anne Murray, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04975464 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04975464's enrollment target sits among peer trials
600 50th of 454 higher than 405 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI